| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |